Shinepharm
ABOUT US

ABOUT US

ABOUT SHINEPHARM

Founded in 2012, Shinepharm is a comprehensive pharmaceutical enterprise integrating R&D, manufacturing and brand management, dedicated to safeguarding global public health.

Rooted in China, Global Presence

  • Globalization: Trademark registered and business operated in 26 countries;
  • Overseas Partnerships: cooperated with high-quality local agents via localized distribution and brand licensing to boost global influence.
Shinepharm pharmaceutical manufacturing campus
15Years Industry Experience
160Products
50Countries

MANUFACTURING & R&D

Shinepharm pharmaceutical manufacturing facilityLarge-Scale Manufacturing Strength
Large-Scale Manufacturing Strength
  • Diverse Product Portfolio: Over 100 premium special-formulation products, covering powder for injection, water injection, tablets, capsules, intravenous infusion and other dosage forms.
  • High Annual Capacity: 300 million units of powder for injection, 1 billion units of water injection, and 3 billion tablets.
Large-Scale Manufacturing Strength
  • Diverse Product Portfolio: Over 100 premium special-formulation products, covering powder for injection, water injection, tablets, capsules, intravenous infusion and other dosage forms.
  • High Annual Capacity: 300 million units of powder for injection, 1 billion units of water injection, and 3 billion tablets.
Quality & Innovation
  • All workshops are cGMP-certified, with strict quality control ensuring full-lifecycle product safety.
  • In-depth industry-university-research cooperation drives industrial upgrading through technological innovation.
  • A full brand strategy upgrade was launched in 2021, with multiple product design patents filed to build a strong independent IP barrier.
Shinepharm pharmaceutical quality control facilityQuality & Innovation
Quality & Innovation
  • All workshops are cGMP-certified, with strict quality control ensuring full-lifecycle product safety.
  • In-depth industry-university-research cooperation drives industrial upgrading through technological innovation.
  • A full brand strategy upgrade was launched in 2021, with multiple product design patents filed to build a strong independent IP barrier.

Committed to premium quality and continuous innovation for human health.